Emily
Editor, Senior Moderator
http://www.marketwatch.com/story/novartis-meningitis-b-vaccine-bexseror-receives-fda-breakthrough-therapy-designation-in-the-us-2014-04-07?reflink=MW_news_stmp
April 7, 2014, 1:17 a.m. EDT
Novartis meningitis B vaccine Bexsero(R) receives FDA Breakthrough Therapy designation in the US